摘要
直接从人类纤维母细胞生成功能性神经元细胞(诱导神经元细胞)的方法最近已经被开发出来,但到目前为止,此项研究只专注于技术的改进或已知病理表型的再现。一个关键的问题是,这项新技术是否将有助于阐明新的疾病机制或评价治疗的策略。这里我们已经解决了这个问题,通过使用具有未成熟有丝分裂后期谷氨酸神经元细胞特性的人诱导神经元细胞来研究戴萨克斯症(一种典型的溶酶体储存疾病)和Dravet综合症(一种严重的婴儿严重肌阵挛性癫痫)。在戴萨克斯症方面,我们已经成功地表征了典型的神经元病理,GM2神经节苷脂的大量积累,并演示了这种新细胞的培养对未来的药物筛选的适应性。在Dravet综合症方面,我们还鉴定了一个新功能表型,其不被经典的小鼠模型和人体大脑解剖研究所推荐。综上所述,目前的研究表明,人诱导神经元细胞在转化神经科学研究中探索新型疾病机制和评估化合物疗效是有益的。在未来,使用人诱导神经元细胞的研究与良好的基因组蓝图可以集成到多学科以患者为中心的神经障碍研究中去,用以解决新疾病的机制和评估治疗的策略。
关键词: 直接转化,诱导神经元细胞,iN 细胞,溶酶体贮积症,离子通道病;多聚谷氨酰胺疾病
Current Molecular Medicine
Title:Clinical Utility of Neuronal Cells Directly Converted from Fibroblasts of Patients for Neuropsychiatric Disorders: Studies of Lysosomal Storage Diseases and Channelopathy
Volume: 15 Issue: 2
关键词: 直接转化,诱导神经元细胞,iN 细胞,溶酶体贮积症,离子通道病;多聚谷氨酰胺疾病
摘要: Methodologies for generating functional neuronal cells directly from human fibroblasts [induced neuronal (iN) cells] have been recently developed, but the research so far has only focused on technical refinements or recapitulation of known pathological phenotypes. A critical question is whether this novel technology will contribute to elucidation of novel disease mechanisms or evaluation of therapeutic strategies. Here we have addressed this question by studying Tay-Sachs disease, a representative lysosomal storage disease, and Dravet syndrome, a form of severe myoclonic epilepsy in infancy, using human iN cells with feature of immature postmitotic glutamatergic neuronal cells. In Tay-Sachs disease, we have successfully characterized canonical neuronal pathology, massive accumulation of GM2 ganglioside, and demonstrated the suitability of this novel cell culture for future drug screening. In Dravet syndrome, we have identified a novel functional phenotype that was not suggested by studies of classical mouse models and human autopsied brains. Taken together, the present study demonstrates that human iN cells are useful for translational neuroscience research to explore novel disease mechanisms and evaluate therapeutic compounds. In the future, research using human iN cells with well-characterized genomic landscape can be integrated into multidisciplinary patient-oriented research on neuropsychiatric disorders to address novel disease mechanisms and evaluate therapeutic strategies.
Export Options
About this article
Cite this article as:
Clinical Utility of Neuronal Cells Directly Converted from Fibroblasts of Patients for Neuropsychiatric Disorders: Studies of Lysosomal Storage Diseases and Channelopathy, Current Molecular Medicine 2015; 15 (2) . https://dx.doi.org/10.2174/1566524015666150303110300
DOI https://dx.doi.org/10.2174/1566524015666150303110300 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Computational Study and Synthesis of a New Class of Anticonvulsants with 6 Hz Psychomotor Seizure Test Activity: 2-(1,3-benzodioxol-5-yloxy)- N'-[substituted]-acetohydrazides
Medicinal Chemistry LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase
Current Signal Transduction Therapy Molecular Docking Study, Green Synthesis and Pharmacological Evaluation of 1,3,4-thiadiazole Derivatives as Potential Antiepileptic Agents
Mini-Reviews in Medicinal Chemistry Preserving Brain Function During Development and Aging with Erythropoietin
Current Neurovascular Research Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews Is Adult Hippocampal Neurogenesis Really Relevant for the Treatment of Psychiatric Disorders?
Current Neuropharmacology Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Aquaporins and Roles in Brain Health and Brain Injury
Mini-Reviews in Medicinal Chemistry AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders
Current Topics in Medicinal Chemistry Carbonic Anhydrase Inhibitors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
Current Neuropharmacology Medical Technology: A Systematic Review on Medical Devices Utilized for Epilepsy Prediction and Management
Current Neuropharmacology Potential Mechanisms Involved in the Anticonvulsant Effect of Methanol Extract of <i>Pyrenancantha staudtii</i> in Mice
Central Nervous System Agents in Medicinal Chemistry Characterization of a New Positive Allosteric Modulator of AMPA Receptors - PAM-43: Specific Binding of the Ligand and its Ability to Potentiate AMPAR Currents
Current Molecular Pharmacology Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology Editorial: Antiepileptic Drugs in Neurosurgical Practic
Current Pharmaceutical Design Neurodegeneration and Neuroprotection in Multiple Sclerosis
Current Pharmaceutical Design Co-Existence of GABA and Glu in the Hippocampal Granule Cells: Implications for Epilepsy
Current Topics in Medicinal Chemistry Targeting Cytokines for Morphine Tolerance: A Narrative Review
Current Neuropharmacology